Novo Nordisk Files Federal Lawsuit Charging Eli Lilly With Deceptive GLP-1 Ad Tactics

By Ed Silverman and Elaine Chen · STAT News · 2026-07-21

STAT News reports that Novo Nordisk is taking legal action against Eli Lilly in New Jersey federal court regarding a national marketing campaign. The Danish pharmaceutical giant alleges that Lilly utilized obsolete clinical data to portray its metabolic treatments as superior to

STAT News reports that Novo Nordisk is taking legal action against Eli Lilly in New Jersey federal court regarding a national marketing campaign. The Danish pharmaceutical giant alleges that Lilly utilized obsolete clinical data to portray its metabolic treatments as superior to